ليست عنوان مقالات لاتين Cardiac oxygenation by extracorporeal membrane oxygenation in exteriorized fetal lambs, , , Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac oxygenation by extracorporeal membrane oxygenation in exteriorized fetal lambs, , ,

2

Cardiac pacemaker cell failure with preserved If, ICaL, and IKr: A lesson about pacemaker function learned from ischemia-induced bradycardia

3

Cardiac pacemaker dysfunction in children after thoracic drainage catheter manipulation

4

Cardiac Pacemaker Infection: Surgical Management With and Without Extracorporeal Circulation

5

Cardiac pacemaker lead extraction using conventional techniques:a single centre experience

6

Cardiac pacemaker: In vitro assessment at 1.5 T

7

Cardiac pacemakers: Evaluation and management of malfunctions

8

Cardiac pacemaking: If vs. Ca2+, is it really that simple?

9

10

11

Cardiac Pacing and Psychologic Disorders

12

Cardiac pacing in balloon aortic valvuloplasty

13

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation

14

Cardiac pacing: atrial fibrillation may go unrecognised

15

Cardiac pacing: the state of the art

16

Cardiac Papillary Fibroelastoma

17

Cardiac papillary fibroelastoma

18

Cardiac papillary fibroelastoma

19

Cardiac papillary fibroelastoma as a reason of transient ischemic attack for a young patient

20

Cardiac papillary fibroelastoma in left ventricular apex

21

Cardiac papillary fibroelastoma manifested as a left ventricular cystic mass

22

Cardiac papillary fibroelastoma on the pulmonary valve: a rare cardiac tumor

23

Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases

24

Cardiac papillary fibroelastomas: Rationale for excision

25

Cardiac Paraganglioma Presenting With Acute Myocardial Infarction and Stroke

26

Cardiac Paraganglioma, Recent Advances in Clinicopathologic Features

27

Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes

28

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

29

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

30

Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women

31

Cardiac pathological changes of Atlantic salmon (Salmo salar L.) affected with heart and skeletal muscle inflammation (HSMI)

32

Cardiac patients’ beliefs about their illness and treatment: A sequential exploratory mixed methods design

33

Cardiac patients’ perception about psychological risk factors on chest pain intensity and discomfort

34

Cardiac pentastomiasis and tuberculosis: The worm-eaten heart

35

Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice

36

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article

37

Cardiac performance early after cardioversion from atrial fibrillation, , , , ,

38

CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

39

Cardiac performance is reduced following high-fat diet

40

Cardiac Performance Measure Compliance in Outpatients: The American College of Cardiology and National Cardiovascular Data Registryʹs PINNACLE (Practice Innovation And Clinical Excellence) Program

41

Cardiac phenotypes in relaxin knockout mice: Importance of the gender

42

Cardiac pheochromocytoma

43

Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan

44

Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis

45

Cardiac Physical Diagnosis in the Digital Age: An Important but Increasingly Neglected Skill (from Stethoscopes to Microchips)

46

Cardiac plasmacytoma

47

Cardiac Positron Emission Tomography

48

Cardiac positron emission tomography and the role of adenosine pharmacologic stress

49

Cardiac Positron Emission Tomography as a Prognostic Indicator of Cardiac Sarcoidosis

50

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

51

Cardiac positron emission tomography imaging with [11c]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

52

Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy

53

Cardiac potassium channel dysfunction in sudden infant death syndrome

54

Cardiac potassium currents and channels: Part II: Implications for clinical practice and therapy

55

Cardiac potassium currents and channels-Part I: Basic science aspects

56

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry Original Research Article

57

Cardiac Power Output during Dobutamine Stress Test in Horses

58

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

59

Cardiac problems related to burns and/or burn treatment

60

Cardiac procedure use following acute myocardial infarction among American Indians

61

Cardiac Procedures in Lung Transplant Recipients Do Not Increase Mortality in Selected Patients

62

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

63

Cardiac progenitor cells application in cardiovascular disease

64

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

65

Cardiac protection: Evolving role of angiotensin receptor blockers

66

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

67

Cardiac pulsations in patients with isolated right ventricular infarction

68

Cardiac Regeneration Review Article

69

Cardiac Rehab: Bridging the Transition from Hospital to Home

70

Cardiac rehabilitation

71

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

72

Cardiac rehabilitation and depression

73

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

74

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

75

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

76

Cardiac Rehabilitation and Survival in Older Coronary Patients

77

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

78

Cardiac Rehabilitation Following Myocardial Infarction

79

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

80

Cardiac rehabilitation I: review of psychosocial factors

81

Cardiac rehabilitation II: referral and participation

82

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

83

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

84

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

85

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

86

Cardiac rehabilitation in the elderly

87

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

88

Cardiac rehabilitation services in England and Wales: a national survey

89

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

90

Cardiac Rehabilitation, Exercise Training, and Anxiety

91

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

92

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

93

Cardiac rehabilitation: A review of current developments

94

Cardiac rehabilitation: How can it be improved?

95

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

96

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

97

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

98

Cardiac remodeling after long term norepinephrine treatment in rats

99

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

100

Cardiac remodeling and failure: From molecules to man (Part I)

101

Cardiac remodeling and failure: From molecules to man (Part II)

102

Cardiac remodeling and failure: From molecules to man (Part III)

103

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

104

Cardiac remodeling in coronary artery disease

105

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

106

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

107

Cardiac remodeling: is 8 the heart’s lucky number?

108

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

109

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

110

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

111

Cardiac reoperation in the intensive care unit

112

Cardiac reoperations in octogenarians: analysis of outcomes

113

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

114

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

115

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

116

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

117

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

118

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

119

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

120

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

121

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

122

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

123

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

124

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

125

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

126

Cardiac resynchronisation – a new standard in heart failure therapy

127

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

128

Cardiac Resynchronisation Therapy in Heart Failure

129

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

130

Cardiac resynchronization by pacing: an electrical treatment of heart failure

131

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

132

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

133

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

134

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

135

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

136

Cardiac Resynchronization Therapy

137

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

138

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

139

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

140

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

141

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

142

Cardiac Resynchronization Therapy for the Failing Fontan Patient

143

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

144

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

145

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

146

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

147

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

148

Cardiac resynchronization therapy in congenital heart disease

149

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

150

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

151

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

152

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

153

Cardiac resynchronization therapy in patients with narrow QRS

154

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

155

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

156

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

157

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

158

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

159

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

160

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

161

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

162

Cardiac resynchronization therapy upregulates cardiac autonomic control

163

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

164

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

165

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

166

Cardiac resynchronization therapy: A regulatory perspective

167

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

168

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

169

Cardiac resynchronization therapy: caveat medicus! Review Article

170

Cardiac Resynchronization Therapy: Location Matters

171

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

172

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

173

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

174

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

175

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

176

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

177

Cardiac retransplantation in children

178

Cardiac rhabdomyoma

179

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

180

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

181

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

182

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

183

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

184

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

185

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

186

Cardiac risk factors

187

Cardiac risk factors

188

Cardiac risk for vascular surgery

189

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

190

Cardiac risk in pregnant women with rheumatic mitral stenosis

191

Cardiac risk management in severe mental illness

192

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

193

Cardiac risk stratification

194

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

195

Cardiac risk: Theme con variations

196

Cardiac rupture – experience-based cardiology

197

Cardiac Rupture After Catheter Ablation Procedure

198

Cardiac rupture and tamponade during ventriculography

199

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

200

Cardiac rupture complicating myocardial infarction

201

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

202

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

203

Cardiac Rupture During Vacuum-Assisted Closure Therapy

204

Cardiac rupture or pericardial effusion?

205

Cardiac Sarcoidosis

206

Cardiac Sarcoidosis

207

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

208

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

209

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

210

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

211

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

212

Cardiac Sca-1+ and side population cells in cardiac regeneration

213

Cardiac screening proposed for HIV-1-infected children

214

Cardiac sensitization: methodology and interpretation in risk assessment

215

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

216

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

217

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

218

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

219

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

220

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

221

Cardiac stabilizer for minimally invasive direct coronary artery bypass

222

Cardiac state diagnosis using adaptive neuro-fuzzy technique

223

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

224

Cardiac Steatosis and Myocardial Dysfunction

225

Cardiac Stem Cell Transplantation

226

Cardiac stem cells and myocardial disease

227

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

228

Cardiac stents: the next generation

229

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

230

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

231

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

232

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

233

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

234

Cardiac structure and function Review Article

235

Cardiac structure and function after short-term ethanol consumption in rats

236

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

237

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

238

Cardiac Structure and Function in Persons 85 Years of Age

239

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

240

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

241

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

242

Cardiac surgeons in England face publication of outcomes data

243

Cardiac surgery

244

Cardiac surgery and cold-reactive proteins

245

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

246

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

247

Cardiac surgery for octogenarians: is it an informed decision?

248

Cardiac surgery in a fixed-reimbursement environment

249

Cardiac surgery in African Americans

250

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

251

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

252

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

253

Cardiac surgery in octogenarians with poor lung function

254

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

255

Cardiac surgery in octogenarians: have we gone too far or not far enough?

256

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

257

Cardiac surgery in patients infected with the human immunodeficiency virus

258

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

259

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

260

Cardiac surgery in patients with end-stage renal disease: 10-year experience

261

Cardiac Surgery in Patients With Liver Cirrhosis

262

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

263

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

264

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

265

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

266

Cardiac surgery report cards: comprehensive review and statistical critique

267

Cardiac surgery report cards: making the grade

268

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

269

Cardiac Surgery Risk Models: A Position Article

270

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

271

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

272

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

273

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

274

Cardiac surgical implications of calcium dyshomeostasis in the heart

275

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

276

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

277

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

278

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

279

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

280

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

281

Cardiac sympathetic innervation and control of potassium channel function

282

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

283

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

284

Cardiac syndrome X versus metabolic syndrome X

285

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

286

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

287

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

288

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

289

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

290

Cardiac tamponade as a life-threatening complication in antireflux surgery

291

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

292

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

293

Cardiac tamponade as manifestation of advanced thymic carcinoma

294

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

295

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

296

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

297

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

298

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

299

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

300

Cardiac tamponade due to pneumopericardium

301

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

302

Cardiac tamponade during thoracic endovascular aortic repair

303

Cardiac tamponade following pacemaker implantation

304

Cardiac tamponade from central venous catheters

305

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

306

Cardiac tamponade in a neglected case of thyroid agenesis

307

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

308

Cardiac tamponade in acquired immunodeficiency syndrome

309

Cardiac tamponade in acute rheumatic fever

310

Cardiac tamponade in Hashimotoʹs disease

311

Cardiac tamponade in hereditary hemorrhagic telangiectasia

312

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

313

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

314

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

315

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

316

Cardiac tamponade without pericardial effusion after blunt chest trauma

317

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

318

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

319

Cardiac teratogenicity of trichloroethylene metabolites

320

Cardiac thromboemboli complicating a stab wound to the heart

321

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

322

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

323

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

324

Cardiac toxicity of sunitinib

325

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

326

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

327

Cardiac Transplant Following Failed Fontan or Glenn Procedures

328

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

329

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

330

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

331

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

332

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

333

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

334

Cardiac transplantation for the cardiologist not trained in transplantation

335

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

336

Cardiac transplantation in a patient with protein S deficiency

337

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

338

Cardiac Transplantation in Adults With Small Hearts

339

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

340

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

341

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

342

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

343

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

344

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

345

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

346

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

347

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

348

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

349

Cardiac troponin I

350

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

351

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

352

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

353

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

354

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

355

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

356

Cardiac troponin I as a marker for AMI

357

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

358

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

359

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

360

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

361

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

362

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

363

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

364

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

365

Cardiac troponin i in acute pericarditis

366

Cardiac troponin I in aortic valve disease

367

Cardiac troponin I in neonates undergoing the arterial switch operation

368

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

369

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

370

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

371

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

372

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

373

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

374

Cardiac troponin I proves less accurate in low-risk cardiac patients

375

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

376

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

377

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

378

Cardiac troponin I release in heart transplantation

379

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

380

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

381

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

382

Cardiac Troponin Increases Among Runners in the Boston Marathon

383

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

384

Cardiac troponin release in response to transient ST segment depression

385

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

386

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

387

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

388

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

389

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

390

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

391

Cardiac troponin T concentration after coronary balloon angioplasty

392

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

393

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

394

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

395

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

396

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

397

Cardiac troponin T levels in umbilical cord blood,

398

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

399

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

400

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

401

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

402

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

403

Cardiac troponin-I content of skeletal muscle in patients with renal failure

404

Cardiac troponins after a downhill marathon

405

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

406

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

407

Cardiac troponins in congestive heart failure, ,

408

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

409

Cardiac troponins in renal insufficiency: Review and clinical implications

410

Cardiac Troponins in Young Marathon Runners

411

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

412

Cardiac troponins: IT upgrade for the heart

413

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

414

Cardiac tuberculosis presenting as small intestinal gangrene

415

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

416

Cardiac tumor due to Erdheim-Chester disease

417

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

418

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

419

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

420

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

421

Cardiac Uses of Phosphodiesterase-5 Inhibitors

422

Cardiac vagal activity: a target for intervention in heart disease

423

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

424

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

425

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

426

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

427

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

428

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

429

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

430

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

431

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

432

Cardiac valve replacement in human immunodeficiency virus–infected patients

433

Cardiac valve replacement in patients on dialysis

434

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

435

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

436

Cardiac Valvular Calcification in Hemodialysis Patients

437

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

438

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

439

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

440

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

441

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

442

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

443

Cardiac Whipple’s disease without digestive symptoms

444

Cardiac Xenotransplantation

445

Cardiac xenotransplantation: clinical experience and future direction

446

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

447

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

448

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

449

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

450

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

451

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

452

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

453

Cardiac-specific Gene Expression: a HANDful of Factors

454

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

455

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

456

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

457

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

458

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

459

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

460

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

461

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

462

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

463

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

464

Cardinal B-spline dictionaries on a compact interval

465

Cardinal characteristics and projective wellorders

466

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

467

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

468

Cardinal characteristics for Menger-bounded subgroups

469

Cardinal directions between spatial objects: the pairwise-consistency problem

470

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

471

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

472

Cardinal functions of Pixley–Roy hyperspaces

473

Cardinal Interpolating Multiresolutions Original Research Article

474

Cardinal interpolation with polysplines on annuli Original Research Article

475

Cardinal invariants about shrinkability of unbounded sets

476

Cardinal invariants above the continuum Original Research Article

477

Cardinal invariants and -factorizability in paratopological groups

478

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

479

Cardinal invariants in locally -minimal paratopological groups

480

Cardinal invariants of monotonically normal spaces

481

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

482

Cardinal invariants related to permutation groups

483

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

484

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

485

Cardinal sequences

486

Cardinal sequences of LCS spaces under GCH

487

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

488

Cardinal temperatures for germination of Kochia scoparia (L.)

489

Cardinal transfer properties in extender models

490

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

491

Cardinalities in depth: a formal approach to partial validation of conceptual schema

492

Cardinalities of ccc-spaces with regular -diagonals

493

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

494

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

495

Cardinality and the borda score

496

Cardinality Approach to Fuzzy Number Arithmetic

497

Cardinality bounds for subdirectly irreducible algebras Original Research Article

498

Cardinality concepts for type-two fuzzy sets

499

Cardinality constrained Boolean quadratic polytope Original Research Article

500

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

501

Cardinality, quantifiers, and the aggregation of fuzzy criteria

502

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

503

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

504

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

505

Cardioactive steroid poisoning from an herbal cleansing preparation

506

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

507

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

508

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

509

Cardiocerebral Resuscitation for Cardiac Arrest

510

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

511

Cardiocerebral Resuscitation: A Broader Perspective

512

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

513

Cardio-cerebrovascular complications in elderly with diabetes

514

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

515

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

516

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

517

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

518

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

519

Cardioembolic Stroke

520

Cardioembolic stroke: an update

521

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

522

Cardio-facio-cutaneous syndrome and moyamoya syndrome

523

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

524

Cardiogenic and Aortogenic Brain Embolism Review Article

525

Cardiogenic shock

526

Cardiogenic shock

527

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

528

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

529

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

530

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

531

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

532

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

533

Cardiogenic shock complicating acute coronary syndromes

534

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

535

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

536

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

537

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

538

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

539

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

540

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

541

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

542

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

543

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

544

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

545

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

546

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

547

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

548

Cardiogenic shock: Basics and clinical considerations

549

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

550

Cardiogenic shock: is there light at the end of the tunnel?

551

Cardiographic conundrum: Adding insult to injury

552

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

553

Cardioinhibitory syncope due to bloodphobia associated asystole

554

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

555

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

556

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

557

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

558

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

559

Cardiological applications of nuclear medicine Review Article

560

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

561

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

562

Cardiologist in the carotids

563

Cardiologist in the dugout

564

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

565

Cardiologist on trial: reflections on credible evidence

566

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

567

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

568

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

569

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

570

Cardiologists in casualty?

571

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

572

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

573

Cardiologists recommend Fragmin

574

Cardiologists versus internists in the care of unstable angin

575

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

576

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

577

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

578

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

579

Cardiology and emergency medicine: United We Stand, divided we fall

580

Cardiology and neurologic family screening in noncompaction

581

Cardiology and the Critical Care Crisis: A Perspective Review Article

582

Cardiology in a Flat World

583

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

584

Cardiology in contemporary China: An update

585

Cardiology in India

586

Cardiology in India: State of the Art or Straight off the Heart?

587

Cardiology in South America

588

Cardiology Integration: Challenge and Opportunity

589

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

590

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

591

Cardiology rounds

592

Cardiology screening on the net

593

Cardiology Workforce Crisis: Shortage or Surplus?

594

Cardiology Workforce Revisited

595

Cardiology workforce: there’s already a shortage, and it’s getting worse!

596

Cardiology, for what itʹs worth

597

Cardiology: “Itʹs small world after all”

598

Cardiology: a call for papers

599

Cardiology: American Journal of Medicine theme issue

600

Cardiology: call for papers

601

Cardiology: the past, the present, and the future

602

Cardiology: where to go from here?

603

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

604

Cardiomegaly in a young infant

605

Cardiometabolic Abnormalities in Current National Football League Players

606

Cardiometabolic Consequences of Gestational Dysglycemia

607

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

608

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

609

Cardio-metabolic risk factors in Iranian children: where we are and the others?

610

Cardiometabolic risk factors in polycystic ovary syndrome

611

Cardiomodulating Activity of Gongronema latifolium and Lisinopril in Doxorubicin-induced Cardiotoxicity in Wistar Rats

612

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

613

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

614

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

615

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

616

Cardiomyocyte death and renewal in the normal and diseased heart

617

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

618

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

619

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

620

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

621

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

622

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

623

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

624

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

625

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

626

Cardiomyocyte Transplantation Improves Heart Function

627

Cardiomyocyte-restricted deletion of connexin43 during mouse development

628

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

629

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

630

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

631

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

632

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

633

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

634

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

635

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

636

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

637

Cardiomyopathic lentiginosis: an echo-Doppler report

638

Cardiomyopathies: from genetics to the prospect of treatment

639

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

640

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

641

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

642

Cardiomyopathy in a Male with Cystinosis

643

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

644

Cardiomyopathy in Danish patients with coeliac disease

645

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

646

Cardiomyopathy in neurological disorders

647

CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.

648

Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis

649

Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy

650

Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports

651

Cardiomyopathy, nephropathy, and death in a 44-year-old man

652

Cardiomyopathy: a role for nitric oxide?

653

Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)

654

Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator

655

Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression

656

Cardiomyoplasty: Is it time to wrap it up?

657

Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ

658

Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease

659

Cardio-Oncology in Iran: Cardio-toxicity Registry

660

Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus

661

Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding

662

Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

663

Cardioplegia in pediatric cardiac surgery: do we believe in magic?

664

Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts

665

Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum

666

Cardioplegia-induced cell swelling: prevention by normothermic infusion

667

Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial

668

Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?

669

Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells

670

Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics

671

Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy

672

Cardioprotection and garlic

673

Cardioprotection and garlic

674

Cardioprotection and garlic

675

Cardioprotection and garlic

676

Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury

677

Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism

678

Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

679

Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger

680

Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage

681

Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin

682

Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase

683

Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion

684

Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action

685

Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least

686

Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist

687

Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery

688

Cardioprotection for Duchenne’s muscular dystrophy, ,

689

Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN

690

Cardioprotection in aged myocardium: Sites of failure in protective signalling

691

Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult

692

Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor

693

Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects

694

Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy

695

Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes

696

Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart

697

Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease

698

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article

699

Cardio-protective and anti-cancer therapeutic potential of Nigella sativa

700

Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem

701

Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)

702

Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals

703

Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets

704

Cardioprotective and neuroprotective roles of oleuropein in olive

705

Cardioprotective and neuroprotective roles of oleuropein in olive

706

Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients

707

Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart

708

Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats

709

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase

710

Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification

711

Cardioprotective effect of chronic hypoxia is blunted by hypercapnia

712

Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning

713

Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting

714

Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart

715

Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats

716

Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial

717

Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration

718

Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion

719

Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways

720

Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats

721

Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats

722

Cardioprotective effect of growth hormone secretagogues in rat heart

723

Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)

724

Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats

725

Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats

726

Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion

727

Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion

728

Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels

729

Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study

730

Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats

731

Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats

732

Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system

733

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat

734

CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY

735

Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI

736

Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts

737

Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis

738

Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?

739

Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention

740

Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats

741

Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats

742

Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

743

Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study

744

Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat

745

Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats

746

Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours

747

Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure

748

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

749

Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article

750

Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury

751

Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism

752

Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins

753

cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure

754

Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart

755

cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice

756

Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury

757

Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart

758

Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia

759

Cardioprotective effects of preinfarction angina in elderly: same patients, different results?

760

Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats

761

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention

762

Cardioprotective effects of the NHE1-inhibitor EMD 87580

763

Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia

764

Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research

765

Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts

766

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article

767

Cardioprotective Potential of Antihypertensives

768

Cardioprotective potential of biobased gold nanoparticles

769

Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia

770

Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits

771

Cardio-protective properties of Momordica charantia in Albino Rats

772

Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats

773

Cardioprotective role of FGF2 in a murine model of low-flow ischemia

774

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model

775

Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals

776

Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery

777

Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran

778

CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL

779

CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA

780

Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting

781

Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery

782

Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation

783

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics

784

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans

785

Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility

786

Cardiopulmonary bypass during pregnancy

787

Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma

788

Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels

789

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant

790

Cardiopulmonary bypass in humans: bypassing unfractionated heparin

791

Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation

792

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis

793

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172

794

Cardiopulmonary bypass in pregnancy

795

Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases

796

Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function

797

Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension

798

Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans

799

Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow

800

Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia

801

Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia

802

Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation

803

Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions

804

Cardiopulmonary bypass, rewarming, and central nervous system dysfunction

805

Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit

806

Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital

807

Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys

808

Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves

809

Cardiopulmonary effects of HI-6 treatment in soman intoxication

810

Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys

811

Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome

812

Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure

813

Cardiopulmonary exercise test evidence of isolated right coronary artery disease

814

Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates

815

Cardiopulmonary exercise test in patients with subacute pulmonary emboli

816

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

817

Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension

818

Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation

819

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article

820

Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation

821

Cardiopulmonary exercise testing in patients with heart failure

822

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article

823

Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure

824

Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma

825

Cardiopulmonary function in adult patients late after Fontan repair

826

Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities

827

Cardiopulmonary hazards of perihepatic packing for major liver injuries,

828

Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain

829

Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application

830

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

831

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

832

Cardiopulmonary mortality and air pollution

833

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

834

Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review

835

Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome

836

Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure

837

Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis

838

Cardiopulmonary responses to robotic end-effector-based walking and stair climbing

839

Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects

840

CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA

841

Cardiopulmonary resuscitation and neurological complications in the elderly

842

Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study

843

Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance

844

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study

845

Cardiopulmonary resuscitation in nursing homes

846

CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY

847

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study

848

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study

849

Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey

850

Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,

851

Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance

852

cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)

853

Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article

854

Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis

855

Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists

856

Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?

857

Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.

858

Cardiopulmonary resuscitation: Historical perspective to recent investigations

859

Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India

860

Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study

861

Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study

862

Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats

863

Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure

864

Cardiorenal Effects of Recombinant Human Natriuretic Peptides

865

Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article

866

Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure

867

Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.

868

Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats

869

Cardiorenal Syndrome

870

Cardiorenal syndrome

871

Cardiorenal Syndrome Review Article

872

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

873

Cardiorenal Syndrome or Renocardiac Syndrome

874

Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure

875

Cardio-renal-anemia syndrome: a report of three cases

876

Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study

877

Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs

878

Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses

879

Cardiorespiratory challenges in Rettʹs syndrome

880

Cardiorespiratory changes during upper gastrointestinal endoscopy

881

Cardio-respiratory control during early development in the model animal zebrafish

882

Cardio-respiratory coupling in untreated patients with major depression

883

CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA

884

Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study

885

Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?

886

Cardiorespiratory fitness and coronary heart disease risk factor association in women

887

Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy

888

Cardiorespiratory Fitness and Metabolic Risk

889

Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review

890

Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension

891

Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study

892

Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention

893

Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template

894

Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents

895

Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study

896

Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)

897

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men

898

Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial

899

Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus

900

Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure

901

Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance

902

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

903

Cardiorespiratory responses to exercise after repair of the univentricular heart

904

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study

905

Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state

906

Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training

907

Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury

908

Cardioscopic guidance of linear lesion creation for radiofrequency ablation

909

Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis

910

CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects

911

CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy

912

Cardiosource is a good source for definition of trial acronyms

913

Cardiospermum halicacabum Linn.: Food and Drug

914

Cardiothoracic Surgeons Divided By a Common Language

915

Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox

916

Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement

917

Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3

918

Cardiothoracic surgery: a specialty in transition—good to great?

919

Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation

920

Cardiotocography and medicolegal issues

921

Cardiotocography in the Prognosis of Perinatal Outcome

922

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article

923

Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial

924

Cardiotocography Waveform Analysis Using Image Extraction Technique

925

Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass

926

Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots

927

Cardiotonic Drugs from the Avicenna's Point of View

928

Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine

929

Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats

930

Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats

931

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

932

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

933

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

934

Cardiotoxicity associated with sunitinib

935

Cardiotoxicity associated with sunitinib

936

Cardiotoxicity associated with sunitinib – Authorsʹ reply

937

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

938

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

939

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

940

Cardiotoxicity of 5-flourouracil: two case reports

941

Cardiotoxicity of cytotoxic drugs

942

Cardiotoxicity of Plants in Iran: a Review

943

Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)

944

Cardiotoxicity Research in Breast Cancer Patients: Past and Future

945

Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised

946

Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience

947

Cardiotrophin-1 in Patients with Acute Myocardial Infarction

948

Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli

949

Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts

950

Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats

951

Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes

952

Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines

953

Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation

954

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy

955

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article

956

Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article

957

Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms

958

Cardiovascular Abnormalities in Hyperthyroidism

959

Cardiovascular abnormalities in hyperthyroidism

960

Cardiovascular Abnormalities in Hyperthyroidism

961

Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study

962

Cardiovascular abnormalities in never-treated hypertensives according to nondipper status

963

Cardiovascular Abnormalities in Sickle Cell Disease

964

Cardiovascular activity and the antibody response to vaccination

965

Cardiovascular adaptations to endurance training and detraining in young and older athletes

966

Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly

967

Cardiovascular Aging: What We Can Learn From Caloric Restriction

968

Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)

969

Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats

970

Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade

971

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

972

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

973

Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus

974

Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

975

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep

976

Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?

977

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

978

Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)

979

Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization

980

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

981

Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency

982

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

983

Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial

984

Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension

985

Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture

986

Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study

987

Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran

988

Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers

989

Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer

990

Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes

991

Cardiovascular anomalies associated with chromosome 22q11.2 deletion

992

Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome

993

Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study

994

Cardiovascular applications for artifical structural proteins produced by recombinant technologies

995

Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS

996

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease

997

Cardiovascular autonomic function in healthy adolescents

998

Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease

999

Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria

1000

Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats

بازگشت